SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009877
Filing Date
2017-05-09
Accepted
2017-05-09 16:21:37
Documents
68
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q advm-10q_20170331.htm 10-Q 1142863
2 EX-31.1 advm-ex311_7.htm EX-31.1 15557
3 EX-31.2 advm-ex312_8.htm EX-31.2 15494
4 EX-32.1 advm-ex321_9.htm EX-32.1 7163
  Complete submission text file 0001564590-17-009877.txt   6099082

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT advm-20170331.xml EX-101.INS 1374371
6 XBRL TAXONOMY EXTENSION SCHEMA advm-20170331.xsd EX-101.SCH 56129
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE advm-20170331_cal.xml EX-101.CAL 51177
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE advm-20170331_def.xml EX-101.DEF 212506
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20170331_lab.xml EX-101.LAB 429795
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20170331_pre.xml EX-101.PRE 334938
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 17826720
SIC: 2836 Biological Products, (No Diagnostic Substances)